Friedrich Miescher Institute for Biomedical Research is a world-renowned research institute located in Basel, Switzerland. It is affiliated with the University of Basel and the Novartis Institutes for BioMedical Research. The institute is named after its founder, Friedrich Miescher, who discovered nucleic acids in 1869.
The institute comprises eight scientific departments and three core facilities, which are all integrated into the university’s medical faculty. The institute’s research focuses on the molecular mechanisms underlying human diseases. In particular, scientists at the institute are interested in understanding how genes are regulated and how this regulation goes awry in disease states. To this end, they use a variety of cutting-edge techniques including DNA sequencing, gene editing, and animal models of disease.
The Friedrich Miescher Institute for Biomedical Research has made many significant contributions to our understanding of human health and disease. Some of their most notable achievements include identifying the genetic cause of cystic fibrosis, demonstrating that cancer cells can arise from healthy cells (a process known as “oncogenesis”), and elucidating how immune cells communicate with one another to fight infection (a process known as “immunology”). In addition to their fundamental research contributions, scientists at the institute also conduct clinical trials testing new treatments for various diseases such as cancer and Alzheimer’s disease.